Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Pharmacotherapy
|
July 1, 1984
Safety of indos
J G Devane, P B Bottini
American Journal of Orthopedics (Belle Mead, N.J.)
|
September 1, 1996
IPDAS: a novel technology brings new benefits when applied to naproxen sodium
J G Devane, J Butler, S Mulligan
American Journal of Therapeutics
|
April 17, 2001
A steady-state evaluation of the bioavailability of chronotherapeutic oral drug absorption system verapamil PM after nighttime dosing versus immediate-acting verapamil dosed every eight hours
L M Prisant, J G Devane, J Butler
Journal of Cardiovascular Pharmacology
|
June 1, 1991
Pharmacokinetic properties and antihypertensive efficacy of once-daily diltiazem
J G Kelly, J G Devane, B Geoghegan
Pharmaceutical Research
|
October 24, 1998
Assessment of regional differences in intestinal fluid movement in the rat using a modified in situ single pass perfusion model
A A Raoof, J Butler, J G Devane
Clinical Pharmacology and Therapeutics
|
March 1, 1990
Clinical and pharmacokinetic properties of a transdermal nicotine patch
S C Mulligan, J G Masterson, J G Devane, et al.
European Journal of Clinical Pharmacology
|
January 1, 1989
Pharmacokinetic properties and clinical efficacy of once-daily sustained-release naproxen
J G Kelly, C D Kinney, J G Devane, et al.
European Journal of Clinical Pharmacology
|
January 1, 1989
Transdermal delivery of nicotine in normal human volunteers: a single dose and multiple dose study
Y B Bannon, J Corish, O I Corrigan, et al.
British Journal of Clinical Practice. Supplement
|
June 1, 1985
The bioavailability of a slow-release verapamil formulation
R J Norris, D C Muirhead, R B Christie, et al.
The American Journal of Cardiology
|
April 30, 1992
New developments in sustained-release antihypertensive therapy: formulation and pharmacokinetic considerations
J G Devane, S Mulligan, M Kavanagh, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Pharmacotherapy
|
July 1, 1984
Safety of indos
J G Devane, P B Bottini
American Journal of Orthopedics (Belle Mead, N.J.)
|
September 1, 1996
IPDAS: a novel technology brings new benefits when applied to naproxen sodium
J G Devane, J Butler, S Mulligan
American Journal of Therapeutics
|
April 17, 2001
A steady-state evaluation of the bioavailability of chronotherapeutic oral drug absorption system verapamil PM after nighttime dosing versus immediate-acting verapamil dosed every eight hours
L M Prisant, J G Devane, J Butler
Journal of Cardiovascular Pharmacology
|
June 1, 1991
Pharmacokinetic properties and antihypertensive efficacy of once-daily diltiazem
J G Kelly, J G Devane, B Geoghegan
Pharmaceutical Research
|
October 24, 1998
Assessment of regional differences in intestinal fluid movement in the rat using a modified in situ single pass perfusion model
A A Raoof, J Butler, J G Devane
Clinical Pharmacology and Therapeutics
|
March 1, 1990
Clinical and pharmacokinetic properties of a transdermal nicotine patch
S C Mulligan, J G Masterson, J G Devane, et al.
European Journal of Clinical Pharmacology
|
January 1, 1989
Pharmacokinetic properties and clinical efficacy of once-daily sustained-release naproxen
J G Kelly, C D Kinney, J G Devane, et al.
European Journal of Clinical Pharmacology
|
January 1, 1989
Transdermal delivery of nicotine in normal human volunteers: a single dose and multiple dose study
Y B Bannon, J Corish, O I Corrigan, et al.
British Journal of Clinical Practice. Supplement
|
June 1, 1985
The bioavailability of a slow-release verapamil formulation
R J Norris, D C Muirhead, R B Christie, et al.
The American Journal of Cardiology
|
April 30, 1992
New developments in sustained-release antihypertensive therapy: formulation and pharmacokinetic considerations
J G Devane, S Mulligan, M Kavanagh, et al.
Page
of 2